Innoveren Scientific Inc. (IVRN)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Apr 29, 2025
Innoveren Scientific Company Description
Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage.
It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023.
The company is headquartered in Tampa, Florida.
Innoveren Scientific Inc.
Country | United States |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 2 |
CEO | Michael Yurkowsky |
Contact Details
Address: 201 East Kennedy Blvd Tampa, Nevada 33602 United States | |
Phone | 844 633 6839 |
Website | innoverenscientific.com |
Stock Details
Ticker Symbol | IVRN |
Exchange | OTCMKTS |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | US4041243076 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Michael W. Yurkowsky | Chief Executive Officer and Director |
Dr. Tanya Rhodes Ph.D. | Chief Scientific Officer |
Jeffery Wright CPA, CPA | Controller and Principal Accounting Officer |